About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
KU ASH 2019 Review on Benign Hematology: Sutimlimab in CAD, Erythroferrone Regulates Fe Homeostasis in Beta Thalassemia, B2GP in APS ELANE Gene Editing in SCN
By
KU ASH 2019 Review: Current Updates in Hematologic Diseases
FEATURING
Penelope Harris
By
KU ASH 2019 Review: Current Updates in Hematologic Diseases
FEATURING
Penelope Harris
25 views
February 24, 2020
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
42:10
Insights from 2023 ASH Annual Meeting
Highlights in Red Cell and Platelet Disorders From ASH 2023
Feat.
M. Blinder
08:11
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "A Novel Beta Globin Frameshift Mutation Cau…
Feat.
L. Bilston
13:57
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Pyruvate Kinase Activators - Targeting Red …
Feat.
K. Kuo
10:22
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
State-of-the-Art in Managing Thalassemias
Feat.
M. Cappellini
18:15
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
Updates in Cellular Therapy for Sickle Cell Disease and Beta-Thalass…
Feat.
S. Peslak
33:17
Indy Hematology Review
Managing Benign Hematology Disorders
Feat.
C. Kessler
16:09
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Case-Based Discussion: Managing Non-Transfusion-Dependent Thalassemia
Feat.
A. Taher
12:24
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
The Role of Luspatercept in Transfusion-Dependent Patients With Beta…
Feat.
A. Tombak
08:41
ASH 2022 Conference Coverage
ASH 2022 Long-Term Outcomes of Patients With TDT Followed Up to 8 Ye…
Feat.
M. Walters
09:49
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Bu-Cy or Treosulfan-Flu-Thiotepa-Based Myeloablative Conditioning fo…
Feat.
N. Bayram
33:24
Zahra Pakbaz
Current Approach to Sickle Cell Anemia: COVID & SCD, Genotypes, …
31:43
Suhag Parikh
Updates on Curative Therapies for Sickle Cell Disease: Allogeneic HS…
10:26
James Taylor
Forms of SCD: Sickle Cell Anemia, Hb SC Disease, Beta/Alpha-Thalasse…
25:01
Indy Hematology Review
Review of Emerging Therapies and Top Trials in Hematologic Malignanc…
Feat.
R. Birhiray
23:18
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
Curative Options for Hemoglobinopathies: Is MSD the SoC in Thalassem…
Feat.
S. Corbacioglu
28:21
KU ASH 2018 Review: Current Updates in Hematologic Diseases
ASH December 2018 - Benign Hematolgy - Analysis of Top Trials
Feat.
P. Harris
17:49
KU ASH 2019 Review: Current Updates in Hematologic Diseases
KU ASH 2019 Review on Benign Hematology: New FDA Approvals, 2nd-Line…
Feat.
P. Harris
19:17
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
Managing Late Complications in Beta Thalassemia: Thrombotic Disease,…
Feat.
V. Huseynov
24:46
UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts
ASH Updates on Non-Malignant Hematology: Mycophenolate for ITP, CTX0…
Feat.
M. Thirman
59:08
Vivien Sheehan
From Genomics to Biomarkers in Sickle Cell Disease: Can Genomics Reg…
